MedWatch

Expecting vaccine breakthrough in three years

Scientists behind a Danish research project are hopeful of a vaccine breakthrough that will benefit all vaccines within three years time. The research team already has a partnership deal in place with the Italian vaccine company Okairis.

Foto: Colourbox

A research team from University of Copenhagen led by associate professor Peter Johannes Holst, Ph. D., expects to have definite results from their research into HIV vaccines within three years. And the results could benefit all types of vaccines, as the research is aimed at strengthening individual vaccines.

“We started out a few months ago, so we can’t really say that we are close. But the group does research into HIV vaccines, and we have already seen a breakthrough in the way infected cells are killed,” says Peter Johannes Holst, pointing out that they will have to wait three years to see definite results.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier